Ex-Lab Members
| Name | Period | Previous Institution | Degree | Research Interest | Current Position |
|---|---|---|---|---|---|
| Abraham Scaria | 1993 - 1994 | St. Louis University | Ph.D. | Adenovirus Vectors | Scientist @ Genzyme |
| M.L. Liu | 1993 - 1996 | Chinese Academia of Sciences | M.D. | Retrovirus Vectors | Research Associate in Seattle |
| Mary Hitt | 1994 - 1995 | UC Berkeley | Ph.D. | Gene Expression in Adenovirus | Assistant Professor @ University of Alberta |
| Marie-Jeanne T.F.D. Vrancken Peeters | 1994 - 1996 | Leiden University | M.D. Ph.D. |
Hepatocyte Transplantation | Surgeon @ Red Cross Hospital, Netherlands |
| Dave Schowalter | 1994 - 2000 | Mayo Med. University | M.D. Ph.D. |
Adenoviral Immunology | Deceased |
| Andre Lieber | 1995 - 1998 | Inst. Med. Moscow & Humboldt Univ. | M.D. Ph.D. |
Hepatitis C | Professor @ University of Washington |
| Jim Nelson | 1995 - 1999 | Wayne State | Ph.D. | Adeno Vectors | Clinical Trials Coordinator @ Univ. Washington |
| G.A. Patijn | 1996 - 1998 | Leiden University | M.D. |
Hepatocyte Transplantation | Consultant Gastrointestinal Surgeon @ Isala Clinics, Netherlands |
| Carol Miao | 1996 - 2000 | University of Washington | Ph.D. | Hemophilia Gene Therapy | Assistant Professor @ University of Washington |
| Hiroyuki Mizuguchi | 1997 - 1998 | Osaka University | Ph.D. | Adenoviral Vectors | Project Leader @ National Institute of Biomedical Innovation, Japan |
| Stephen Yant | 1997 - 2006 | University of Michigan | Ph.D. | Integrating Gene Transfer Vectors | Research Scientist @ Gilead |
| Kazuo Ohashi | 1998 - 2002 | Nara Medical University | M.D. Ph.D. |
Liver Tissue Engineering; Cell-Based Gene Therapy, Hepatocyte Transplantation | Assistant Professor @ Tokyo Women's Medical University |
| Frank Park | 1998 - 2002 | Medical College of Wisonsin | Ph.D. | Lenti Vectors | Assistant Professor @ Louisiana State University |
| Hiroyuki Nakai | 1998 - 2004 | Kyoto Pref. University of Medicine | M.D. Ph.D. |
AAV Vectors | Assistant Professor @ University of Pittsburgh |
| Peter Peng | 1999 - 2002 | Stanford University | M.S. | Gene Therapy for Diabetes | Fellow @ NIH |
| Brian Garrison | 1999 - 2002 | UC Davis | B.S. | HCV Therapeutics | Research Fellow @ Harvard University |
| Anton McCaffrey | 1999 - 2004 | University of Colorado | Ph.D. | HCV Therapeutics | Assistant Professor @ University of Iowa |
| Anja Ehrhardt | 1999 - 2004 | University of Hannover | Ph.D. | Adenovirus Vectors | Faculty @ Max von Pettenkofer Institute, Germany |
| Julie Park | 1999 - 2005 | MIT | B.S. | Non-Viral Vectors | Stanford University |
| Alfred Wang | 1999 - 2006 | Stanford University | M.S. | ||
| Chong W. Yung | 2000 - 2002 | Harvard University | M.S. Ph.D. |
Regulatorable DNA Vectors | Research Fellow in Surgery @ Harvard University |
| Konrad Streetz | 2000 - 2005 | University of Hannover | M.D. Ph.D. |
Animal Models for Human Liver Cells | The University Hospital, Aachen, Germany |
| Efren Riu Pastor | 2000-2007 | Univ. of Barcelona | Ph.D. | Approaches for In Vivo Gene Therapy for Hemophilia | Research Fellow @ Universitat Autònoma de Barcelona |
| Clare Thomas | 2001 - 2003 | University of Leeds | Ph.D. | AAV Mechanism for Transduction | Associate Editor for Nature Medicine |
| Jacob G. Mikkelsen | 2001 - 2003 | Aarhus University | Ph.D. | Gene Transfer Vectors for Use in Human Gene Therapy | Associate Professor @ Aarhus University |
| Nandita Nath | 2003 - 2004 | University of Delhi | Ph.D. | Anti-Viral Therapies | Scientist @ Milagen |
| Bassel Akache |
2005 - 2006 | McGill University, Montreal, Quebec, Canada | Ph.D. | AAV Mechanism of Transduction | Senior Research Scientist @ Methylgene Inc. |
| Xuan Shen | 2003-2007 | University of South Caroina | Ph.D. | Viral Vectors, Gene Therapy and Liver Diseases | Scientist, MedImmune |
| Michael Hebert | 2005-2007 | University of Texas | Ph.D. | AAV and Hemophilia B | Technical Specialist @ Foley & Lardner LLP |
| Dirk Grimm | 2001-2007 | German Cancer Research Center (DKFZ), Heidelberg | Ph.D. | AAV and Hemophilia B | Leader of CHS group 'Virus-Host Interactions' University of Heidelberg |
| Dirk Haussecker | 2005-2009 | Oxford University, United Kingdom | Ph.D. | HDV-mediated amplification of therapeutic RNAi | TBD |
